{"CONCEPT_ID":[4194895,4295638,4087235,4167605,42538680,40481096,36713464,756055,4092969,4097664,4095027,4048727,43020943,4147961,4099476,4198132,4046263,4246053,4264765,36713462,4055657,4098179,42538681,42538811,4353510,4102739,4064918],"CONCEPT_PATH":["Procedure by method||Procedure by intent||Screening procedure||Screening for disorder","Protein level - finding||Specific antibody level - finding||Finding of HIV status||HIV CDC stage finding","Procedure by intent||Screening procedure||Screening at times of life||Antenatal screening","NA||Staging and scales||Assessment scales||Barthel index","Screening procedure||Screening for neoplasm||Screening for cancer||Screening for malignant neoplasm of stomach","Screening procedure||Screening for neoplasm||Screening for cancer||Screening for malignant neoplasm of prostate","Screening procedure||Screening at times of life||Antibody screen||Antenatal screening for isoimmunization","Measurement||Measurement of substance||Measurement of Coronavirus (Coronavirinae subfamily species)||Measurement of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","Laboratory test||Immunology laboratory test||Clinical immunological test||In vivo test of hypersensitivity","Measurement||Measurement of substance||Protein measurement||Albumin measurement","Measurement of substance||Protein measurement||Antibody measurement||Antibody titer measurement","Screening procedure||Screening for disorder||Screening for neoplasm||Screening for cancer","Screening procedure||Screening for disorder||Chromosome abnormality screening||Fetal chromosomal abnormality screening","Screening for disorder||Screening for neoplasm||Screening for cancer||Screening for malignant neoplasm of breast","Tumor marker measurement||Measurement of substance in specimen||Fluid sample AFP level||Alpha-1-Fetoprotein measurement, amniotic fluid","Laboratory test||Hematology procedure||Hematology test||Hematology screening test","Measurement||Measurement of substance||Protein measurement||Enzyme measurement","Procedure by method||Laboratory procedure||Laboratory test||Blood test","Procedure by site||Physical examination||Taking patient vital signs||Blood pressure taking","Screening procedure||Screening for developmental disorder||Screening for congenital malformation||Antenatal screening for malformation","Measurement||Measurement of substance||Protein measurement||Serum/plasma protein test","Procedure by method||Laboratory procedure||Laboratory test||Immunology laboratory test","Screening procedure||Screening for neoplasm||Screening for cancer||Screening for malignant neoplasm of intestinal tract","Screening for neoplasm||Screening for cancer||Screening for malignant neoplasm of urinary system||Screening for malignant neoplasm of urinary bladder","Measurement||Measurement of substance||Protein measurement||Globulin measurement","Procedure by intent||Screening procedure||Screening for disorder||Screening for cardiovascular system disease","Procedure by intent||Screening procedure||Screening for disorder||Diabetes mellitus screening"],"NUM_PERSONS":[704,704,528,528,264,264,264,264,264,264,264,264,264,264,264,264,176,176,176,176,176,176,88,88,88,88,88],"PERCENT_PERSONS":[0.000102579047063966,0.000102579047063966,7.69342852979746e-05,7.69342852979746e-05,3.84671426489873e-05,3.84671426489873e-05,3.84671426489873e-05,3.84671426489873e-05,3.84671426489873e-05,3.84671426489873e-05,3.84671426489873e-05,3.84671426489873e-05,3.84671426489873e-05,3.84671426489873e-05,3.84671426489873e-05,3.84671426489873e-05,2.56447617659915e-05,2.56447617659915e-05,2.56447617659915e-05,2.56447617659915e-05,2.56447617659915e-05,2.56447617659915e-05,1.28223808829958e-05,1.28223808829958e-05,1.28223808829958e-05,1.28223808829958e-05,1.28223808829958e-05],"RECORDS_PER_PERSON":[1.78125,1.71875,1.70833333333333,1.75,1.58333333333333,1.75,1.66666666666667,1.91666666666667,1.58333333333333,1.83333333333333,1.41666666666667,1.83333333333333,1.58333333333333,1.58333333333333,1.66666666666667,1.75,1.75,1.75,2,1.75,1.875,1.875,2,1.75,1.75,2,1.5]}
